CDK15 and colorectal carcinoma: CDK15 reduction inhibited cell proliferation, anchorage-independent growth of CRC cells and tumor progression in patient-derived xenograft (PDX) model, through the regulation of β-catenin and MEK/ERK signaling cascades to drive oncogenic pathway of CRC cells, both in vivo and in vitro.461